Small bowel dose parameters predicting grade ≥3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: An independent validation study comparing peritoneal space versus small bowel loop contouring techniques

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages 1225-1231

  Banerjee, Robyn ^a   Chakraborty, Santam ^a   Nygren, Ian ^a   Sinha, Richie ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE PARAMETERS; DOSE-VOLUME HISTOGRAMS; LOGISTIC REGRESSIONS; METHODS AND MATERIALS; NEOADJUVANT CHEMORADIATION; RADIATION TREATMENTS; RECEIVER OPERATING CHARACTERISTIC ANALYSIS; VALIDATION STUDY;

DISEASES; FORECASTING; LOGISTICS; PATIENT MONITORING; PATIENT TREATMENT;

TOXICITY;

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM CARCINOMA; RETROPERITONEUM; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANS AT RISK; PERITONEAL CAVITY; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEX FACTORS;

EID: 84875235665     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.036     Document Type: Article

References (19)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
3. M. Braendengen, K.M. Tveit, and A. Berglund Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer J Clin Oncol 26 2008 3687 3694
4. J.M. Robertson, M. Sohn, and D. Yan Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model Int J Radiat Oncol Biol Phys 77 2010 66 72
5. M.J. Gallagher, H.D. Brereton, and R.A. Rostock A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation Int J Radiat Oncol Biol Phys 12 1986 1565 1573
6. K.L. Baglan, R.C. Frazier, and D. Yan The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 52 2002 176 183
7. J.M. Robertson, D. Lockman, and D. Yan The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 413 418
8. L.M. Tho, M. Glegg, and J. Paterson Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning Int J Radiat Oncol Biol Phys 66 2006 505 513
9. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
10. E.Y. Huang, C.C. Sung, and S.F. Ko The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry Int J Radiat Oncol Biol Phys 69 2007 732 739
11. A. Gunnlaugsson, E. Kjellen, and P. Nilsson Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer Acta Oncol 46 2007 937 944
12. B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S101 S107
13. Jhingran A, Miller B, Portelance L, et al. Radiation Therapy Oncology Group RTOG 0418: A phase II study of intensity modulated radiation therapy (IMRT) to the pelvis ± chemotherapy for post-operative patients with either endometrial or cervical carcinoma. Protocol. Broadcast date August 25, 2011.
14. Pollack A, Low D, Watkins-Bruner D, et al. Radiation Therapy Oncology Group RTOG 0534: A phase III trial of short term androgen deprivation with pelvic lymph node or prostate bed only radiotherapy (SPPORT) in prostate cancer patients with a rising PSA after radical prostatectomy. Protocol. Broadcast date January 11, 2011.
15. G. Sanguineti, M. Little, and E.J. Endres Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer Radiother Oncol 88 2008 95 101
16. L.B. Marks, E.D. Yorke, and A. Jackson Use of normal tissue complication probability models in the clinic Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S10 S19
17. B.D. Minsky, J.A. Conti, and Y. Huang Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer J Clin Oncol 13 1995 1409 1416
18. R. Hofheinz, F.K. Wenz, and S. Post Capecitabine versus 5-fluorouracil based neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Long-term results of a randomized phase III trial J Clin Oncol 29 suppl 2011 abstr 3504
19. M.S. Roh, G.A. Yothers, and M.J. O'Connell The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 J Clin Oncol 29 suppl 2011 abst 3503